Skip to Primary Navigation

Biotech company avoids DOJ charges after self-reporting payment of bribes

Close up of Mexican Peso banknotes and coins.
Photo: Getty Images

Lifecore Biomedical, Inc.’s efforts in self-reporting FCPA violations lead to declination decision from DOJ.

Lifecore Biomedical, Inc., formerly known as Landec Corporation, has received a declination with disgorgement from the US Department of Justice (DOJ) for Foreign Corrupt Practices Act (FCPA) violations in Mexico. The company is a biotech firm with its principal offices in California but is incorporated in Delaware.

The DOJ’s declination